Clin2
NCT07464119Possibly a fitNot yet recruiting

Lab-made insulin cells for diabetes treatment

Diabetes Mellitus

Part of Hormones & metabolism clinical trials.

This trial studies a new treatment made from special cells that can make insulin for people with diabetes. The goal is to see if these cells can help control blood sugar and reduce the need for insulin injections.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years old or older.
  • You must have had diabetes for more than 5 years.
  • You must have a body mass index (BMI) between 18 and 35.
  • You must be currently using insulin.
  • You cannot have serious infections like HIV, hepatitis, tuberculosis, or other uncontrolled infections.
  • You cannot have severe diabetes complications, serious organ damage, or a history of cancer.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06415643Recruiting
Lab-grown islet cells for diabetes after pancreas surgery

This trial tests whether lab-grown islet cells (pancreatic organoids) can help control blood sugar in people who develop diabetes after having most or all of their pancreas removed. If successful, this could reduce the need for insulin shots.

Hangzhou, Zhejiang
NCT07118475Enrolling by invitation· Early Phase 1
Islet transplant for type 2 diabetes

This trial tests whether transplanting your own insulin-making cells (islets) can help control blood sugar if you have type 2 diabetes and your pancreas is not making enough insulin. The goal is to reduce or stop your need for insulin injections.

Shanghai
NCT06751199Recruiting
Stem cells combined with islet transplant for diabetes

This trial tests if umbilical cord stem cells can improve the success of islet cell transplants for people with diabetes whose own pancreas no longer makes enough insulin. It aims to help patients achieve better blood sugar control and reduce dangerous low blood sugar episodes.

Shanghai, Shanghai Municipality
NCT05973734Enrolling by invitation· Phase 1
Islet transplant with immune cells to treat type 1 diabetes

This Phase 1 study tests a new immune-system strategy around islet transplantation (or donor bone marrow therapy) to improve control of type 1 diabetes and reduce dangerous low blood sugar. It mainly aims to see if the approach is safe and helpful in people with long-standing, difficult-to-manage diabetes.

Palo Alto, California
NCT07503028Enrolling by invitation· Early Phase 1
Stem cell therapy for severe low blood sugar in diabetes

This trial tests a new treatment made from stem cells that may help people with diabetes who have dangerous low blood sugar episodes. It aims to see if these cells can replace some of the pancreas function and prevent severe hypoglycemia.

Hefei, Anhui
NCT07479134Recruiting
Producing stem cells for pancreatic cell research

This study collects skin or blood samples to create stem cells that can be turned into insulin-producing pancreatic cells. It may help people with diabetes and other beta cell disorders by providing cells for future research or treatments.

Milan

Hear when a new Diabetes Mellitus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.